- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03575091
Physiotherapy for Infants With Bronchiolities
September 24, 2021 updated by: Lund University
Physiotherapy Including Frequent Changes of Body Position and Stimulation to Physical Activity for Infants With Bronchiolitis and Other Acute Respiratory Infections - a Randomized Controlled Trial
Children who are in a hospital with respiratory distress often have difficulty breathing, have thick mucus, and may find it hard to eat normally.
Sometimes physical therapy is used to treat these children, but it is not entirely known which methods help the children's condition.
The aim of this study is to evaluate the most common physiotherapy treatment method that is currently in use in Sweden for infants who are hospitalized with a lower respiratory infection.
Study Overview
Status
Recruiting
Conditions
Intervention / Treatment
Detailed Description
All children under 2 years of age who are admitted to the hospital for a respiratory infection and who have previously been essentially healthy are asked to participate.
The infants will be randomized to 3 groups, 1 control group and 2 intervention groups.
The infants in the control group will receive the standard care at the clinic.
In one intervention group the parents will receive instructions how to vary their child body position regularly, and in the other intervention group the child will receive physiotherapy regularly and the parents will carry out some treatment.
Further actions in the form of inhalations or stimulation of deep breathing, will be used when needed.
The children will be observed following a structured observational protocol regularly throughout the hospital stay.
Study Type
Interventional
Enrollment (Anticipated)
120
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: Sonja Andersson Marforio, MSc
- Phone Number: +46768092399
- Email: sonja.andersson_marforio@med.lu.se
Study Contact Backup
- Name: Eva Ekvall Hansson, PhD
- Phone Number: +46462221986
- Email: eva.ekvall-hansson@med.lu.se
Study Locations
-
-
-
Malmö, Sweden, SE 20502
- Recruiting
- Skane University Hospital
-
Contact:
- Sonja Andersson Marforio, MSc
- Phone Number: +4646178404
- Email: sonja.andersson_marforio@med.lu.se
-
Växjö, Sweden, 352 34
- Recruiting
- Centrallasarettet
-
Contact:
- Sonja Andersson Marforio, MSc
- Email: sonja.andersson_marforio@med.lu.se
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
1 second to 2 years (Child)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Infants hospitalized because of respiratory infections such as bronchiolitis, pneumonia or other airway obstructions.
- Age 0-24 months
- Born in gestation week 35 or later.
- Guardians understand written Swedish, English, Arabic or Persian
Exclusion Criteria:
- Previous cardiac or respiratory disease
- hospitalized more than 24 hours on this occasion
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
No Intervention: control group
The infants will receive the standard care at the ward.
|
|
|
Experimental: Non-individualized
The parents will be guided manually by the nursing staff and receive written information about how to change body positions of their child regularly throughout the hospital stay.
|
Comparing two experimental interventions with standard care
|
|
Experimental: Individualized
The infant will receive frequent changes of body positions, stimulation to physical activity, and stimulation to deep breathing while bouncing on a large ball in the arms of an adult.
Additional light chest compressions and inhalations may be given.
A physiotherapist will perform the intervention at least once daily, and the parents will be manually guided and receive written information about how to change body positions of their child regularly in a similar way throughout the hospital stay.
|
Comparing two experimental interventions with standard care
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Time to improvement
Time Frame: Baseline, after 20 minutes, and every third hour up to discharge from hospital, no more than two weeks
|
First improvement regarding any of the following: Wang respiratory score, use of supplemented oxygen, use of supplemented high air flow, use of tube feeding, hospital stay
|
Baseline, after 20 minutes, and every third hour up to discharge from hospital, no more than two weeks
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
oxygen saturation
Time Frame: Baseline and second assessment, directly following the first intervention (or interval) after 20 minutes
|
Change in percutanous oxygen saturation measured by probe on the foot
|
Baseline and second assessment, directly following the first intervention (or interval) after 20 minutes
|
|
respiratory rate
Time Frame: Baseline and second assessment, directly following the first intervention (or interval) after 20 minutes
|
Change in manually counted RR during one minute
|
Baseline and second assessment, directly following the first intervention (or interval) after 20 minutes
|
|
Heart rate
Time Frame: Baseline and second assessment, directly following the first intervention (or interval) after 20 minutes
|
Change in pulse oximeter
|
Baseline and second assessment, directly following the first intervention (or interval) after 20 minutes
|
|
General condition, parents' assessment
Time Frame: Baseline and every third hour up to discharge from hospital, no more than two weeks
|
Time to the first reduction in Numeric Rating Scale 0-10, (0 the best, 10 the worst)
|
Baseline and every third hour up to discharge from hospital, no more than two weeks
|
|
Lung complications
Time Frame: At discharge from the ward, no more than two weeks
|
Referral to an intensive care unit
|
At discharge from the ward, no more than two weeks
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
General Publications
- Andersson-Marforio S, Lundkvist Josenby A, Hansen C, Ekvall Hansson E. Physiotherapy interventions encouraging frequent changes of the body position and physical activity for infants hospitalised with bronchiolitis: an internal feasibility study of a randomised control trial. Pilot Feasibility Stud. 2022 Mar 30;8(1):76. doi: 10.1186/s40814-022-01030-2. Erratum in: Pilot Feasibility Stud. 2022 May 19;8(1):104.
- Andersson-Marforio S, Lundkvist Josenby A, Ekvall Hansson E, Hansen C. The effect of physiotherapy including frequent changes of body position and stimulation to physical activity for infants hospitalised with acute airway infections. Study protocol for a randomised controlled trial. Trials. 2020 Sep 21;21(1):803. doi: 10.1186/s13063-020-04681-9.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
January 23, 2018
Primary Completion (Anticipated)
May 31, 2022
Study Completion (Anticipated)
December 31, 2022
Study Registration Dates
First Submitted
October 13, 2017
First Submitted That Met QC Criteria
June 29, 2018
First Posted (Actual)
July 2, 2018
Study Record Updates
Last Update Posted (Actual)
September 30, 2021
Last Update Submitted That Met QC Criteria
September 24, 2021
Last Verified
September 1, 2021
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- 2017/190
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
No
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
product manufactured in and exported from the U.S.
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.